Korea Prime Pharm aims to achieve 60 billion won in this year’s sales with the intention of emerging as one of the R&D oriented companies in Korea, a company executive said.
“We will reach 60 billion won in sales this year as part of our VISION 5Y600 (2006-2010),” said Kim Dae-ki, Korea Primes’s CEO.
The company signed a memorandum of understanding with local universities and research cen...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.